A new drug reduces risk of psychosis relapse in patients with dementia
Read now →Pimavanserin has not received approval from the FDA, but study results are encouraging
Soren Emerson
Neuroscience
Vanderbilt University
Soren Emerson is a an entering first year PhD student in the Vanderbilt University neuroscience program. He previously attended, and graduated from, Davidson College with a B.S. in neuroscience. He conducted three years of independent research at Davidson College under the mentorship of Dr. Mark Smith, a behavioral pharmacologist, and Dr. Rachid El Bejjani, a C. elegans neurobiologist. His research modeled the genetic and molecular mechanism of cocaine in C. elegans and the results of the project yielded a first author publication. At Vanderbilt, Soren plans to continue his research career in neuropharmacology.
What nematodes laying eggs tells us about how cocaine affects the brain
Read now →New research uncovers a link between cocaine and acetylcholine that could eventually lead to new treatments for addiction
Laughing gas could be the next tool against treatment-resistant depression
Read now →A small clinical trial shows promise for people who don't find relief from antidepressants
Drinking way, way too much coffee might shrink your brain
Read now →Up to five cups of coffee per day seems to be fine. Six or more? Your brain is going to feel it
New machine learning approach can identify your circadian rhythm from a blood sample
Read now →Doctors do not currently monitor a person's circadian rhythms because there is not an efficient way to measure them
Modified tree resins prevent zebrafish from having seizures
Read now →Could these resins also be used to treat epilepsy in humans?
.jpeg?auto=compress%2Cformat&crop=faces&fit=crop&fm=jpg&h=800&q=70&w=1200)
Tapering off opioids is treacherous for mental health
Read now →A large-scale study shows how the opioid epidemic has created downstream negative health outcomes
Drug overdose deaths in the US jumped nearly 30 percent in 2020
Read now →The story behind these numbers is complex, but opioids have played a major role
Psilocybin reduced depression symptoms as much as a leading antidepressant
Read now →New research compared the "magic mushrooms" component to Lexapro